Asensus Surgical, Inc. Deferred Tax Assets, Valuation Allowance
Asensus Surgical, Inc. had Deferred Tax Assets, Valuation Allowance of $110.51 million as of 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2024-03-21
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $110.51M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $94.70M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $78.29M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $67.31M; Deferred Tax Assets, Valuation Allowance as first filed $132.93M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2023-12-31 | $110.51M 10-K · filed 2024-03-21 | |
| 2022-12-31 | $94.70M 10-K · filed 2024-03-21 | |
| 2021-12-31 | $78.29M 10-K · filed 2023-03-02 | |
| 2020-12-31 | $67.31M 10-K · filed 2022-02-28 | $132.93M 10-K · filed 2021-03-11 |
| 2019-12-31 | $123.11M 10-K · filed 2021-03-11 | |
| 2012-12-31 | $10.69M 10-K · filed 2013-04-01 | |
| 2011-12-31 | $8.06M 10-K · filed 2013-04-01 |